Veto Process
No veto information available
Quintuplet
TEAM BLT
| Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|
| kimmy | 249 | 31 / 29 / 11 | 149 | 85% | 3 - 1 | 15% |
| hemoglobean | 218 | 29 / 32 / 10 | 135 | 77% | 0 - 1 | 25% |
| Zyxl | 198 | 23 / 31 / 7 | 123 | 58% | 5 - 4 | 22% |
| yvie | 186 | 23 / 31 / 14 | 115 | 66% | 4 - 7 | 25% |
| Ling2X | 187 | 27 / 33 / 15 | 116 | 59% | 2 - 10 | 41% |
| HS% | FK/FD | KAST | ADR | K/D/A | ACS | Player |
|---|---|---|---|---|---|---|
| 15% | 3 - 1 | 85% | 149 | 31 / 29 / 11 | 249 | kimmy |
| 25% | 0 - 1 | 77% | 135 | 29 / 32 / 10 | 218 | hemoglobean |
| 22% | 5 - 4 | 58% | 123 | 23 / 31 / 7 | 198 | Zyxl |
| 25% | 4 - 7 | 66% | 115 | 23 / 31 / 14 | 186 | yvie |
| 41% | 2 - 10 | 59% | 116 | 27 / 33 / 15 | 187 | Ling2X |
Quintuplet
TEAM BLT
| Agent | Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|---|
|
kimmy | 226 | 10 / 14 / 6 | 133 | 86% | 1 - 1 | 13% |
|
hemoglobean | 229 | 11 / 13 / 4 | 141 | 79% | 0 - 1 | 26% |
|
Zyxl | 228 | 10 / 14 / 0 | 140 | 50% | 2 - 1 | 29% |
|
yvie | 156 | 6 / 13 / 6 | 99 | 57% | 1 - 2 | 29% |
|
Ling2X | 86 | 4 / 14 / 1 | 56 | 43% | 0 - 5 | 44% |
| HS% | FK/FD | KAST | ADR | K/D/A | ACS | Player | Agent |
|---|---|---|---|---|---|---|---|
| 13% | 1 - 1 | 86% | 133 | 10 / 14 / 6 | 226 | kimmy |
|
| 26% | 0 - 1 | 79% | 141 | 11 / 13 / 4 | 229 | hemoglobean |
|
| 29% | 2 - 1 | 50% | 140 | 10 / 14 / 0 | 228 | Zyxl |
|
| 29% | 1 - 2 | 57% | 99 | 6 / 13 / 6 | 156 | yvie |
|
| 44% | 0 - 5 | 43% | 56 | 4 / 14 / 1 | 86 | Ling2X |
|
Quintuplet
TEAM BLT
| Agent | Player | ACS | K/D/A | ADR | KAST | FK/FD | HS% |
|---|---|---|---|---|---|---|---|
|
kimmy | 272 | 21 / 15 / 5 | 164 | 83% | 2 - 0 | 17% |
|
Ling2X | 287 | 23 / 19 / 14 | 176 | 74% | 2 - 5 | 38% |
|
hemoglobean | 206 | 18 / 19 / 6 | 128 | 74% | 0 - 0 | 24% |
|
yvie | 215 | 17 / 18 / 8 | 130 | 74% | 3 - 5 | 20% |
|
Zyxl | 168 | 13 / 17 / 7 | 106 | 65% | 3 - 3 | 14% |
| HS% | FK/FD | KAST | ADR | K/D/A | ACS | Player | Agent |
|---|---|---|---|---|---|---|---|
| 17% | 2 - 0 | 83% | 164 | 21 / 15 / 5 | 272 | kimmy |
|
| 38% | 2 - 5 | 74% | 176 | 23 / 19 / 14 | 287 | Ling2X |
|
| 24% | 0 - 0 | 74% | 128 | 18 / 19 / 6 | 206 | hemoglobean |
|
| 20% | 3 - 5 | 74% | 130 | 17 / 18 / 8 | 215 | yvie |
|
| 14% | 3 - 3 | 65% | 106 | 13 / 17 / 7 | 168 | Zyxl |
|